Prevalence and degree of control of cardiovascular risk factors in patients with ischemic cardiopathy of an urban health center

e202102040

Authors

  • Miguel Ángel Mendoza Alarcón Facultad de Medicina. Universidad de Extremadura. Extremadura. España.
  • Manuel Tejero Mas Centro de Salud Universitario “La Paz”. Servicio Extremeño de Salud. Badajoz. España.
  • José Antonio Morales-Gabardino Unidad Medicalizada de Emergencias de Cabeza del Buey. Servicio Extremeño de Salud. Badajoz. España.
  • Francisco Buitrago-Ramírez Facultad de Medicina. Universidad de Extremadura. Extremadura. España. / Centro de Salud Universitario “La Paz”. Servicio Extremeño de Salud. Badajoz. España.

Keywords:

Coronary heart disease, Secondary prevention, Cardiovascular risk factors, Smoking, Hypertension, Dyslipidemia

Abstract

Background: Compliance with the therapeutic objectives recommended in the clinical practice guidelines on cardiovascular prevention and changes in lifestyle, such as smoking cessation, reduce the morbidity and mortality of patients with ischemic heart disease. The objective of this study was to analyze the prevalence and degree of control of the main cardiovascular risk factors in patients with ischemic heart disease.
Methods: A total of 200 patients with ischemic heart disease randomly selected between the years 2008-2018. The degree of control of the cardiovascular risk factors and the achievement of the recommended objectives in secondary cardiovascular prevention were analyzed during a mean follow-up of 5 years. A descriptive and inferential analysis of the data was performed with the SPPS version 22.0 program.
Results: 77.9% of patients (mean age 65.6 years, 63.2 men and 70.5 women, p<0.01) had high blood pressure, 69.3% dyslipidemia, 48.2% obesity and 32.3% diabetes. 34.8% were smokers (39.2% of men versus 25.4% of women, p=0.06). During the follow-up, a slight decrease in smoking was observed (from 34.8% to 21.6%, p<0.01), with a greater percentage reduction in men versus women (42.9% versus 21.3%, p<0.01). In the follow-up, he also highlighted the decrease in blood pressure, total cholesterol and LDL-cholesterol. Optimal compliance with therapeutic objectives was achieved in 21.7% of patients.
Conclusions: The objectives of secondary cardiovascular prevention are reached in a low percentage of patients with ischemic heart disease, with a lower rate of smoking cessation in women.

Downloads

Download data is not yet available.

References

Instituto Nacional de Estadística. Defunciones según la Causa de Muerte Año 2017. Disponible en: https://www.ine.es/prensa/edcm_2017.pdf. Último acceso: 6 de junio, 2019.

Ferreira-González I. Epidemiología de la enfermedad coronaria. Rev Esp Cardiol 2014; 67:139-144

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev Esp Cardiol 2016; 69(10):939.e1-e87.

Brotons C, Permanyer G, Moral I, Ribera A, Cascant P, Pinar J, en nombre del Grupo de Investigación del estudio PREMISE. Prevención secundaria del infarto de miocardio y calidad de vida relacionada con la salud. Med Clin (Barc). 2002;119:9-12.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D et al; EUROASPIRE Investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019; 26:824-835.

Ribera JA, Peiró S. Prevención secundaria de la cardiopatía isquémica y perspectiva de género en dos centros de atención primaria. Med Clín (Barc) 2006; 286-288.

Okunrintemi V, Valero-Elizondo J, Patrick B, Salami J, Tibuakuu M), Ahmad S et al. Gender differences in patient-reported outcomes among adults with atherosclerotic cardiovascular disease. J Am Heart Assoc. 2018. doi: 10.1161/JAHA.118.010498

Woodward M. Cardiovascular disease and the female disadvantage. Int J Environ Res Public Health. 2019. doi: 10.3390/ijerph16071165

Brotons C, Soriano N, Moral I, Rodrigo MP, Kopple P, Rodríguez AI et al, en nombre del equipo investigador del estudio PREseAP. Rev Esp Cardiol 2011; 64:13-20.

Sánchez DP, Guillén JJ, Torres AM, Sánchez FI. Análisis de la dispensación de medicamentos para el control de los principales factores de riesgo cardiovascular en la Región de Murcia: ¿existen diferencias de género?. Aten Primaria 2014; 46:147-155.

Aguilar-Palacio I, Malo S, Lallana M, Feja C, González J), Moreno-Franco B et al. Co-prescription patterns of cardiovascular preventive treatments: a cross-sectional study in the Aragon worker’ health study (Spain). BMJ Open. 2019. doi: 10.1136/bmjopen-2018-023571

Published

2021-02-16

How to Cite

1.
Mendoza Alarcón M Ángel, Tejero Mas M, Morales-Gabardino JA, Buitrago-Ramírez F. Prevalence and degree of control of cardiovascular risk factors in patients with ischemic cardiopathy of an urban health center: e202102040. Rev Esp Salud Pública [Internet]. 2021 Feb. 16 [cited 2024 Nov. 21];95:6 páginas. Available from: https://ojs.sanidad.gob.es/index.php/resp/article/view/628